NEW YORK STOCK EXCHANGE, INC. · EVMN
+2.99% · +$0.2800 · Vol 1.5M
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Evommune Inc

Evommune Inc

Biotechnology
$9.65
Card
Relationship Map

Follow $EVMN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $EVMN by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
EVMN
Evommune Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

40/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EVMN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EVMN catalysts
About Evommune Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2025
Employees
48
Country
US

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.39
Day high
$9.75
Day low
$9.20
Previous close
$9.37
52W high
$31.57
-69.43% from high
52W low
$9.20
2% of range
Market cap
$350.2M
EPS
$-3.0600
Beta
-0.31
Shares out
36.3M
Volume
1.5M
2.54× rel vol
Avg volume
588.7K
VWAP
$9.60
Price history computed in-house
1W
-7.48%
1M
-31.17%
3M
-60.21%
YTD
-43.63%
SMA 50 $12.38 · below
SMA 200 $19.51 · below
52W position 2%

EVMN overview

Veridion Score
40
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EVMN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EVMN Form 4 filings
Public disclosures

Congress activity in EVMN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EVMN in the cached public ledger.

Federal contracts

EVMN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EVMN in this window.
Lobbying spend

EVMN lobbying filings, year to date.

Registered lobbying filings matched to Evommune Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EVMN in this window.
Loading news for EVMN
Analyst ratings
Sovereign unlock shows live analyst consensus for EVMN.
Options
Sovereign unlock shows live options positioning for EVMN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.